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ABSTRACT  42 
Eight previously undescribed compounds, including four alkaloids and five 43 
styryllactones together with 36 known compounds were isolated from the twig and 44 
leaf extracts of Goniothalamus cheliensis. Their structures were elucidated by 45 
extensive analysis of their spectroscopic data. The absolute configuration of (−)-46 
(4S,5S,6R,7S,8S)-goniochelienlactone and (−)-(4S,5S,6R,7S,8S)-7-47 
acetylgoniochelienlactone were established from single crystal X-ray analysis using 48 
Cu Kα radiation. The absolute configurations of the other related compounds were 49 
identified by comparisons of their ECD spectra with those of related known 50 
compounds. Most of the isolated compounds were evaluated for their cytotoxicities 51 
against human colorectal cancer cells (HCT-116). Griffithazanone A was the most 52 
potent with an IC50 value of 2.39 µM.  53 
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1.  Introduction 83 
  Goniothalamus is the one of the largest genera of the family Annonaceae. It is 84 
distributed throughout the world and is found predominately in Southeast Asia (Duc 85 
et al., 2016). This genus includes about 160 species, of which 25 are found in 86 
Thailand (Saunders et al., 2008). Some species have been used as traditional 87 
medicines for the treatment of fever (Surivet and Vatèle, 1999), scabies (Heyne, 88 
1950), edema, rheumatism (Jiang et al., 2011), tympanites (Quismbing, 1951), and 89 
typhoid fever (Efdi et al., 2010). Goniothalamus cheliensis Hu is a large green tree 90 
which is distributed throughout the forested slopes at 1500 m, in South Yunnan, 91 
China (Saunders et al., 2008). This plant is found in the Northern parts of Thailand, 92 
especially in Chiang Rai and Nan Provinces. Previous phytochemical investigations 93 
of G. cheliensis, resulted in the isolation and identification of various types of 94 
compounds, including styryllactones (Jiang et al., 2011; Wang et al., 2002; Zhu et al., 95 
2012, Duc et al., 2016; Wang et al., 2003, Si et al., 2002), alkaloids (Jiang et al., 2008; 96 
Duc et al., 2016), flavonoids (Wang et al., 2003, Sun et al., 2014), and acetogenins 97 
(Duc et al., 2016). Many of these isolated compounds exhibited a variety of biological 98 
activities such as antiproliferative (Sun et al., 2014), antifungal (Duc et al., 2016), 99 
antimalarial (Duc et al., 2016) and cytotoxic activities (Wang et al., 2002; Zhu et al., 100 
2012). In this study, we describe the isolation and identification of eight previously 101 
undescribed compounds (1−3 and 5−9) and 36 known compounds (4 and 10−44)  102 
(Fig. 1) from the twig and leaf extracts of G. cheliensis collected from Doi Tung, 103 
Chiang Rai Province, Thailand. Their cytotoxicities against the colon cancer cell line 104 
HCT-116 are also reported.    105 
2. Results and Discussion 106 
 The acetone extracts of the leaves and twigs of G. cheliensis were individually 107 
subjected to separation by silica gel and Sephadex LH-20 column chromatography 108 
(CC) followed by semipreparative RP-HPLC to afford eight previously undescribed 109 
compounds (1−3 and 5−9) and 36 known compounds (4 and 10−44). The known 110 
compounds were identified as 3-methyl-1H-benz[f]indole-4,9-dione (4) (Efdi et al., 111 
2010), (−)-goniobutenolide B (10) (Xu et al., 1994), 7-epi-(−)-goniobutenolide B (11) 112 
(Popsavin et al., 2012), (+)-goniodiol (12) (Fang et al., 1991), goniodiol-8-113 
monoacetate (13) (Wu et al., 1992), (+)-7-O-acetylgoniodiol (14) (Kampong et al., 114 
2013), 8-acetoxy goniofufurone (15) (Zhang et al., 1998), isoaltholactone (16) 115 
(Colegate et al., 1990), (+)-glaberide I (17) (Wu et al., 2013), (−)-glaberide I (18) 116 
(Chang et al., 2015), (+)-syringaresinol (19) (Rahman et al., 2007; Yamauchi et al., 117 
2015), (+)-medioresinol (20) (Nakasone et al., 1996; Yamauchi et al., 2015), (+)-118 
episyringaresinol (21) (Chen et al., 1998), (−)-syringaresinol (22) (Rahman et al., 119 
2007; Yamauchi et al., 2015), (−)-episyringaresinol (23) (Lui et al., 2015), (−)-120 
pinoresinol (24) (Ming et al., 2001; Yamauchi et al., 2015), griffithazanone A (25) 121 
(Zhang et al., 1999), cleistopholine (26) (Waterman and Muhammad, 1985), vanillic 122 
acid (27) (Wu et al., 2000), p-hydroxybenzoic acid (28) (Rukachaisirikul et al., 2010), 123 
p-methylbenzoicacid (29) (Zhou et al., 2013), 4-hydroxy-3-methoxypropiophenone 124 
(30) (Ito et al., 2001), 3,5-dimethoxy-4-hydroxypropiophenone (31) (Zdero et al., 125 
1986), p-hydroxybenzaldehyde (32) (Zhou et al., 2013), ethyl-4-hydrozybenzoate (33) 126 
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(Fan et al., 2016), trans-ferulic acid (34) (Salum et al., 2010), (–)-(3R)-mellein methyl 127 
ether (35) (Li et al., 2017), derrusnin (36) (East et al., 1969), 5-hydroxy-7-methoxy-128 
3',4'-methylene dioxy isoflavone (37) (Liping et al., 1996), derrustone (38) (Singh and 129 
Muthukrishnan, 2005), robustone methyl ether (39) (East et al., 1969), derrugenin 130 
(40) (Ortega et al., 2015), robustigenin (41) (Pancharoen et al., 2008), methyl-BRM-5 131 
(42) (Tahara et al., 1986), trans-N-coumaroyltyramine (43) (Holzbach and Lopes, 132 
2010), and N-trans-feruloyl tyramine (44) (Holzbach and Lopes, 2010) by comparison 133 
of their spectroscopic data with those published.   134 
 Compound 1, goniochelienic acid A, was obtained as yellow needles. The core 135 
structure of compound 1 was a benzo[f]indole-4,9-dinone (Efdi et al., 2010) which 136 
was confirmed by a single-crystal X-ray diffraction analysis using Mo Kα radiation 137 
(Fig. 5). The HRESIMS spectrum showed a [M + Na]+ ion peak at m/z 294.0379 138 
(calcd. for C14H9NO5Na, 294.0378) which also supported this structural assignment. 139 
The 1H NMR spectrum of 1 (Table 1) showed resonances for a hydroxy proton of a 140 
carboxylic acid [δH 13.68 (COOH)], a H-bonded hydroxy proton [δH 12.20 (1H, s, 8-141 
OH)], aromatic protons of an ABC spin system [δH 7.82 (1H, d, J = 7.4 Hz, H-5)/δC 142 
120.7, 7.64 (1H, dd, J = 7.8, 7.4 Hz, H-6)/δC 136.0, 7.32 (1H, d, J = 7.8 Hz, H-7)/δC 143 
126.1], an olefinic proton [δH 7.74 (1H, s, H-2)/δC 138.0], and a N-methyl group [δH 144 
4.15 (3H, s, N-CH3)/δC 37.5]. The structure of 1 was further supported by the 145 
following key HMBC correlations (Fig. 3): δH 12.20 (8-OH) with C-7 (δC 126.1), C-8 146 
(δC 162.5), and C-8a (δC 114.5); δH 7.82 (H-5) with C-4 (δC 183.1) and C-6 (δC 147 
136.0); δH 4.15 (N-Me) with C-9a (δC 130.9), C-2 (δC 138.0); δH 7.74 (H-2) with C-3 148 
(δC 114.5), C-3a (δC 123.5), C-9a (δC 130.9), and C-10 (δC 161.5). From these data, 149 
the structure of compound 1 was assigned as 8-hydroxyl-1-methyl-4,9-dioxy-1H-150 
benz[f]indole-3-catboxylic acid. Full assignments of the 1H and 13C NMR 151 
spectroscopic data are shown in Table 1. 152 
 Compound 2, goniochelienic acid B, was isolated as a yellow powder. Its 153 
molecular formula, C14H9NO4, was established by the HRESIMS which showed a [M 154 
+ Na]+ ion peak at m/z 278.0436 (calcd. for C14H9NO4Na, 278.0429). The 
1H and 13C 155 
NMR spectroscopic data (Table 1) of 2 were similar to those of 1. The main 156 
difference between these two compounds was that the H-bonded proton at δH 12.22 157 
(OH-8) was not observed in the 1H NMR spectrum of 2. Compound 2 showed 1H 158 
NMR resonances for four aromatic protons, that formed part of a 1,2-disubstituted 159 
aromatic ring, at δH 8.26 (1H, dd, J = 1.3, 7.4 Hz, H-5), 7.79 (1H, td, J = 1.5, 7.5 Hz, 160 
H-6), 7.81 (1H, td, J = 1.5, 7.5 Hz, H-7), 8.21 (1H, dd, J = 7.4, 1.3 Hz, H-8) instead 161 
of the ABC spin system observed in the 1H NMR spectrum of compound 1. Finally, 162 
the structure of 2 was supported with the following key HMBC correlations (Fig. 3): 163 
δH 8.26 (H-5) with C-4 (δC 184.0) and C-6 (δC 134.5); δH 4.16 (N-Me) with C-9a (δC 164 
131.8), C-2 (δC 137.5); δH 7.73 (H-2) with C-3 (δC 116.4), C-3a (δC 123.1), C-9a (δC 165 
131.8), and C-10 (δC 162.1). Therefore, compound 2 was assigned as 1-methyl-4,9-166 
dioxy-1H-ben[f]indole-3-carboxylic acid.  167 
 Compound 3, methyl goniochelienate, was isolated as a yellow amorphous 168 
powder. The molecular formula C14H9NO4 was deduced from HRESIMS analysis 169 
which showed a [M + Na]+ at m/z 278.0435 (calcd for C14H9NO4Na, 278.0429). The 170 
 
5 
 
1H NMR spectroscopic data of 3 (Table 1) were similar to those of 4; whose structure 171 
was determined by single crystal X-ray structural analysis (Fig. 6). The difference 172 
between compounds 3 and 4 is that 3 has a C-3 methoxy carbonyl substituent (δH 173 
3.89) and 4 has a C-3 methyl group. The position of the methoxy group in 3 was 174 
confirmed by the HMBC correlation from δH 3.89 (3-CO2Me) with C-10 (δC 163.2) 175 
(Fig. 3). The other key HMBC correlations were shown in Fig. 3. Therefore, the 176 
structure of 3 was identified as methyl 4,9-dioxo-1H-benz[f]indole-3-catboxylate.    177 
 Compound 5 was obtained as a yellow solid. The molecular formula of 5 was 178 
established as C13H11NO5 based on the HRESIMS (m/z 284.0530 [M + Na]
+, calcd for 179 
C13H11NO5Na 284.0535). The 
1H and 13C NMR spectra of 5 in CDCl3 solution shown 180 
resonances characteristic of a naphthoquinone derivative (Table 2), which were 181 
similar to those of goniothalaminone B (45), previously isolated from Goniothalamus 182 
scortechinii (Prawat et al., 2012). The significant difference between these two 183 
compounds was observed for the chemical shift of H-7/C-7 and H-8/C-8. Compound 184 
5 displayed these resonances at δH 7.05 (1H, d, J = 8.4 Hz, H-7)/δC 113.2 and 7.75 185 
(1H, d, J = 8.4 Hz, H-8)/δC 121.0, whereas for goniothalaminone B these appeared at 186 
δH 7.22 (1H, d, J = 8.4 Hz, H-7)/δC 117.8 and δH 7.76 (1H, d, J = 8.4 Hz, H-8)/δC 187 
120.7 (Table 2). In addition, the chemical shifts for C-2, C-3 and C-6 were also 188 
different; δC 106.9 (C-2) and δC 158.4 (C-3) 155.8 (C-6) for compound 5 and δC 109.4 189 
(C-2), δC 152.5 (C-3) and δC 152.1 (C-6) for goniothalaminone B. These data 190 
indicated that compound 5 was a structural isomer of goniothalamin B. To help 191 
further assign all 1H NMR resonances as well as to confirm the location of amino 192 
group, the NMR spectra of compound 5 were also recorded in DMSO-d6. The 
1H 193 
NMR spectrum in DMSO-d6 (Table 2) showed addition downfield resonances at δH 194 
9.12 (1H, br s) and δH 10.68 (1H, br s) assignable to the primary amine protons. 195 
Finally, the structure was further confirmed from the following HMBC correlations: 196 
δH 10.68 (2-NH2) with C-1 (δC 178.1); δH 3.91 (6-OMe) with C-6 (δC 155.8); δH 13.94 197 
(5-OH) with C-6 (δC 155.8), C-5 (δC 151.6), C-4a (δC 114.3); δH 7.62 (H-8) with C-1 198 
(δC 178.1), C-8a (δC 121.8), and C-7 (δC 114.7) (Fig. 3 and S27). Thus, the structure 199 
of 5 was identified as goniochelieninone, a structural isomer of goniothalamin B. Full 200 
assignments of the 1H and 13C NMR spectroscopic data are shown in Table 2 and the 201 
COSY and selected HMBC correlations in Fig. 3.   202 
Plausible biosynthetic pathways of compounds 1−5 are shown in Fig.11. 203 
Compounds 1−4 and 5 might arise from difference polyketide units (Wagoner et al., 204 
2008; King et al., 2009; Bauer et al., 2010). The benzo[f]indole-4,9-diones 1−4 could 205 
be obtain from a hexaketide generated from an isobutyryl-CoA starter and a five 206 
acetyl-CoA extender (Zhou et al., 2016) involving multi-steps including the 207 
incorporation of nitrogen (Fig. 11a) (Wagoner et al., 2008; Bauer et al., 2010). 208 
Compound 4 undergoes oxidation of the methyl group to give the carboxylic acid 209 
derivative (4a), esterification of 4a would yield compound 3. Alternatively, 4a was 210 
regioselectively N-methylated to obtain compound 2 which was then oxidized at C-8 211 
to give compound 1. The naphthoquinone 5 might arise from heptaketide (Fig. 11b) 212 
with the similar process of 4.                   213 
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 Compound 6 was isolated as a colorless prism. Analysis of its HRESIMS 214 
showed a [M + Na]+ ion peak at m/z 273.0749 (calcd for C13H14O5Na, 273.0739) 215 
which established the molecular formula C13H14O5. The 5,7-dihydroxy-8-216 
phenylbicyclo[3.3.1]nonan-2-one based structure and the absolute configuration 217 
(4S,5S,6R,7S,8S) of compound 6 were established by single-crystal X-ray diffraction 218 
analysis using Cu Kα radiation (Fig. 7) with the flack parameter of -0.04(7). The ECD 219 
spectrum of 6 (Fig. 9) displayed a negative Cotton effect at 227 nm, similar to that of 220 
parvistone D and parvistone E (Liuo et al., 2014) which also supported the 221 
identification of its absolute configuration. The 1H NMR spectrum further supported 222 
this structure and showed resonances for the mono substituted aromatic ring at δH 7.38 223 
(2H, d, J = 7.9 Hz, H-2ʹ/6ʹ), 7.30 (2H, d, J = 7.6 Hz, H-3ʹ/5ʹ) and 7.26 (1H, d, J = 7.2 224 
Hz, H-4ʹ). The structure of compound 6 was almost identical to that of (+)-225 
goniopypyrone except for the configuration at C-7 which was 7S for compound 6 and 226 
7R for (+)-goniopypyrone (Tsubuki et al., 1999; Zhang et al., 1998). The 1H NMR 227 
spectroscopic data of these two compounds were significantly different, except for the 228 
aromatic proton chemical shifts, as shown in Table S1. Thus, compound 6 was 229 
assigned as (−)-(4S,5S,6R,7S,8S)-goniochelienlactone, the C-7 epimer of (+)-230 
goniopypyrone.   231 
 Compound 7 was isolated as a colorless prism. Its molecular formula 232 
C15H16O6 was established the HRESIMS analysis which showed a [M + Na]
+ ion peak 233 
at m/z 315.0854 (calcd for C15H16O6Na, 315.0845). The core structure of compound 7 234 
was a [3.3.1] bicyclic, similar to that found in compound 6. A single-crystal X-ray 235 
diffraction analysis of compound 7 using Cu Kα radiation established the structure of 236 
compound 7 and its absolute configuration as 4S,5S,6R,7S,8S (Fig. 8) with the Flack 237 
parameter 0.00 (11). Its ECD spectrum (Fig. 9) was similar to that of compound 6 238 
which showed the Cotton effect at 232 nm to support the 4S,5S,6R,7S,8S 239 
configuration.  The full assignments of its 1H and 13C NMR spectroscopic data are 240 
summarized in Table 3. It should be noted that compound 7 is the C-7 is epimer of 7-241 
acetylgoniopypyrone (Zhang et al., 1998). Differences were also observed between 242 
these epimers from their 1H NMR spectra, especially the chemical shifts for the 243 
[3.3.1] bicyclic protons as shown in Table S2. Thus, the structure of 7 was identified 244 
as (−)-(4S,5S,6R,7S,8S)-7-acetylgoniochelienlactone. 245 
  Compound 8, (+)-(7S,8S)-goniochelienbutenolide A, was obtained as a 246 
colorless viscous oil. Its molecular formula C15H14O5 was deduced from its 247 
HRESIMS (m/z 297.0730 [M + Na]+, calcd for C15H14O5Na, 297.0739). The 
1H and 248 
13C NMR spectroscopic data of 8 were similar to those of goniobutenolide A (Fang et 249 
al., 1991). The main difference between compounds 8 and goniobutenolide A was that 250 
compound 8 displayed an additional 1H NMR resonance for acetoxy protons at δH 251 
2.12. Additionally, the resonances for H-7 (δH 5.10) and H-8 (δH 5.88) of compound 8 252 
were shifted downfield compared to the same protons of goniobutenolide A, [δH 4.98 253 
(H-7) and 4.94 (H-8)], (SI Table S3 and S4). The HMBC correlations between H-8 254 
(δH 5.85) with the acetate carbonyl carbon (δC 168.0), H-2ʹ/H-6ʹ (δH 7.40) with C-8 (δC 255 
76.5) and H-7 (δH 4.98) with C-8 (δC 76.5) supported the position of the acetoxy group 256 
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at C-8 (Fig. 3). The relative stereochemistry of 8 was proposed to be ethyro based on 257 
the coupling constant of H-7/H-8 (J7,8 = 6.0 Hz) indicating their syn orientation (J7,8 = 258 
6–8 Hz) (Fang et al., 1991, Shing et al., 1994; Xu et al., 1994). The Z-geometry of C-259 
5/C-6 was determined from a comparison of the 1H NMR spectroscopic data to those 260 
of 7-epi-goniobutenolide A and B (SI Table S3 and S4). The absolute configuration of 261 
8 (7S,8S) was proposed by the comparison of its ECD spectrum to that of compound 262 
11 which showed a negative Cotton effect at 230 and 274 nm (Fig. 10). Thus, the 263 
structure of compound 8 was deduced as (7S,8S,Z)-5-(3-acetyl-2-hydroxy-3-264 
phenylpropylidene)-2(5H)-furanone.  265 
 Compound 9, (−)-(7S,8R)-goniochelienbutenolide B, was obtained as a 266 
colorless viscous oil. It molecular formula C15H14O5 was established by HRESIMS 267 
(m/z 297.0746 [M + Na]+, calcd for C15H14O5Na, 297.0739). The 
1H NMR 268 
spectroscopic data of 9 were similar to that of 8 (Table 4 and SI Fig.S3), but H-3 (δH 269 
6.19) of compound 9 showed long range coupling with that of H-6 (δH 5.82) with the J 270 
value of 1.5 Hz indicating the E-geomety at the exo-cyclic alkene isomer of 271 
compound 9 (Fang et al., 1991; Popsavin et al., 2012). The oxymethine protons of C-7 272 
and C-8 were assigned the threo configuration on the basis of their coupling constant 273 
J7,8 = 4.2 Hz (Fang et al., 1991; Shing et al., 1995; Popsavin et al., 2012). The 274 
absolute configuration of 9 as 7S,8R was proposed from the comparison of its ECD 275 
spectrum to that of 10 (Fig. 10). Therefore, the structure was characterized as (7S, 8R, 276 
E)-5-(3-acetyl-2-hydroxy-3-phenylpropylidene)-2(5H)-furanone.  277 
Annonaceae is a large family containing over 120 genera (Saripalli and Dixit, 278 
2013). Each genus produces different major phytochemicals. For example, 279 
polyoxygenated cyclohexenes are commonly found in many species of Uvaria (Awale 280 
et al., 2017; Lekphrom et al., 2018; Hsu et al., 2016; Kaweetripob et al., 2015; 281 
Auranwiwat et al., 2017; Macabeo et al., 2017), but they are also found in some 282 
species of Artabotrys (Liu et al., 2018), Cleistochlamys (Nyandoro et al., 2017), 283 
Dasymaschalon (Hongthong et al., 2015), Ellipeiopsis (Kijjoa et al., 2002), and 284 
Monanthotaxis (Starks et al., 2012) genera. Flavonoids are major compounds from 285 
many genera including Desmos (Clement et al., 2017; Tuntipaleepun et al., 2012; Kuo 286 
et al., 2015; Prachyawarakorn et al., 2013; Bajgai et al., 2011; Rittiwong et al., 2011), 287 
and Friesodielsia (Meesakul et al., 2017; Prawat et al., 2012; Fleischer et al., 1997; 288 
Joseph et al., 2007), while alkaloids, including aristololactams, aporphines and 289 
oxoprotoberberine, are commonly found in the Miliusa (Promchai et al., 2018; 290 
Promchai et al., 2016; Hasan et al., 2000; Chen et al., 2003; Harrigan et al., 1994) and 291 
Fissistigma (Ge et al., 2013; Zhou et al., 2016; Zhou et al., 2018; Chia et al., 2000) 292 
genera. Styryllactones are the major compounds found in Goniothalamus (Moharam 293 
et al., 2012; Macobeo et al., 2013; Zhang et al., 1998; Fang et al., 1991., Suchaichit et 294 
al., 2015, Hisham et al., 2000; Uma et al., 2012) and Polyalthia (Nantapap et al., 295 
2015; Nurunajah et al., 2001; Samoath and Vasanthi, 2013) whereas acetogenin 296 
(Moghadamtousi et al., 2015; Dang et al., 2011; Melot et al., 2009; Liaw et al., 2008; 297 
Sun et al., 2017; Guzmán et al., 2009; Liaw et al., 2004; Queiroz et al., 2003) and 298 
diterpenoids (Supudompol et al., 2004; Li et al., 2005; Li et al., 2009; Deepralard et 299 
al., 2007; Meng et al., 2007) were found in Annona and Mitrephora. 300 
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 Most of the isolated compounds (1, 2, 4, 6, 7, 10, 12–14, 16, 19, 22, 25, 27, 301 
28, 30, 31, 34, 36–39) were evaluated for their cytotoxicities against the colon cancer 302 
cell line HCT-116. Only compound 25 (griffithazanone A) showed potent cytotoxicity 303 
with an IC50 value of 2.39 µM (doxorubicin as a positive control had an IC50 value of 304 
9.74 µM). All remaining compounds were inactive (IC50 ˃50 µM). The IC50 value of 305 
compound 25 against HCT-116 is less than those against human cervical cancer cells 306 
(20.2 µM and 11.7 µM for KB cells and HeLa cells, respectively) (Tip-pyang et al., 307 
2010). Indicating that the cytotoxic effect of compound 25 is not cell-line specific and 308 
that compound 25 may be more effective against colorectal cancer cell lines than 309 
cervical cancer cell lines.   310 
 311 
3. Conclusions 312 
 The phytochemical investigation of the extracts of the G. cheliensis led to the 313 
identification of 44 compounds, of which eight were previously undescribed 314 
compounds (1–3, 5, and 6–9). The discovery of styryllactones as the major 315 
compounds was in good agreement with the previous report of this genus (Moharam 316 
et al., 2012; Macobeo et al., 2013; Zhang et al., 1998; Fang et al., 1991., Suchaichit et 317 
al., 2015, Hisham et al., 2000; Uma et al., 2012). To the best of our knowledge, the 318 
indole alkaloids 1–3 and alkaloid 5 were found in this species for the first time. In a 319 
previous paper, the [3.3.1] bicyclic core structure of compounds 6 and 7 was reported 320 
as having the 7R configuration (Fang et al., 1991; Tsubuki et al., 1999; Zhang et al., 321 
1998), however, we report herein related compounds having the 7S configuration with 322 
their absolute configurations being confirmed by single-crystal X-ray diffraction 323 
analysis. The isolated compounds were found to have no cytotoxicities against the 324 
colon cancer cell line HCT-116 at 50 µM except for griffithazanone A (25) which had 325 
potent cytotoxicities. This compound may have potential as a lead compound for the 326 
development of new anti-cancer agents.  327 
 328 
4. Experiment section 329 
4.1. General experiment procedures 330 
 The optical rotation [α]D values were determined with a Bellingham and 331 
Stanley ADP400 polarimeter. Melting points were measured with a Buchi B-540 332 
melting point apparatus. UV-vis spectra were recorded with Varian Cary 5000 UV-333 
vis-NIR spectrophotometer. The IR spectra were recorded using a Perkin-Elmer FTS 334 
FT-IR spectrophotometer. Electronic circular dichroism spectra were recorded on a 335 
JASCO J-815 CD spectropolarimeter. The NMR spectra were recorded using Bruker 336 
Avance 600 MHz spectrometers. Chemical shifts are reported in parts per million (δ), 337 
and coupling constants (J) are expressed in hertz. HRESIMS spectra were obtained on 338 
a Bruker-Hewlett-Packard 1100 Esquire-LC system mass spectrometer. Single-crystal 339 
X-ray diffraction measurements were made on a Bruker APEX DUO diffractometer 340 
with cross-coupled multilayer optics Cu-Kα radiation. HPLC was performed on a 341 
Waters 1525 HPLC pump system, equipped with a Waters 2487 dual λ absorbance 342 
detector using the following column: Phenomenex Luna 5u C8 column (10 × 250 mm) 343 
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and CHIRALCEL OD-H column (4.6 × 250 mm). Quick column chromatography 344 
(QCC) and column chromatography (CC) were carried out on Si gel 60 H (5−40 µm, 345 
Merck), Si gel 100 (63−200 µm, Merck) or silica gel 100 (63−200 µm, SiliCycle® 346 
Inc.), respectively. Waters 10 g Sep-Pak’s were used for reversed-phase flash 347 
chromatography. Sephadex LH-20 was also used for CC. Precoated plates of silica gel 348 
60 F254 were used for analytical purposes. 349 
 350 
4.2 Plant material 351 
 The twigs and leaves of Goniothalamus cheliensis Hu (Annonaceae) were 352 
collected from Doi Tung, Chiang Rai Province, Thailand (GPS coordinates: 353 
20o17.351ʹ N, 99o48.661ʹ E), in October 2015, winter. The plant material was 354 
authenticated by Mr. Martin van de Bult (Doi Tung Development Project, Chiang Rai, 355 
Thailand), and a voucher specimen (MFU-NPR0146) was deposited at the Natural 356 
Products Research Laboratory, School of Science, Mae Fah Luang University. 357 
 358 
4.3 Extraction and isolation 359 
 The dried twigs of G. cheliensis (5.1 kg) were extracted with acetone. The 360 
acetone extract (41.2 g) was subjected to QCC eluting with a gradient solvent system 361 
of n-hexanes-acetone (1:0 to 0:1, v/v) to afford 11 fractions (A−K). Fraction D (2.3 g) 362 
was subjected to Sephadex LH-20 (100% MeOH) to yield seven subfractions 363 
(D1−D7). Fraction D4 (95.8 mg) was subjected to Sep-Pak C18 CC, eluted with 364 
MeOH-H2O (3:2, v/v) to yield subfraction D1A. Fraction D1A (61.6 mg) was 365 
separated over Sephadex LH-20 to give 4 subfractions (D1A-1−D1A-4). Fraction 366 
D1A-2 (40.4 mg) was fractionated using silica gel CC eluting with n-hexanes-acetone 367 
(7:3, v/v) to obtained 6 subfractions (D1A-2-1−D1A-2-6). Fraction D1A-2-2 (4.5 mg) 368 
was chromatographed using RP C18 HPLC (eluted with CH3CN/H2O with 0.05% 369 
TFA, 1:1, 2 mL/min) to give compounds 29 and 32 (0.3 mg, tR = 11.6 min), 30 (1.0 370 
mg, tR = 15.6 min), and 33 (0.9 mg, tR = 18.5 min). Compound 31 (2.1 mg, tR = 15.6 371 
min) was obtained from D1A-2-3 by RP C18 HPLC (eluted with CH3CN/H2O with 372 
0.05% TFA, 1:1, 2 mL/min). Fraction D5 (205.0 mg) was subjected to Sep-Pak C18 373 
CC, eluted with MeOH-H2O (3:2, v/v) to give subfraction D5A (172.6 mg) following 374 
separated by Sephadex LH-20 (100% MeOH) to yield 4 subfractions (D5A-1−D5A-4). 375 
Compound 35 (3.9 mg) and 28 (1.4 mg) were purified from D5A-2 (47.5 mg) by silica 376 
gel CC eluting with n-hexanes-acetone (7:3, v/v). Fraction D7 (29.4 mg) was 377 
subjected to Sep-Pak C18 CC eluting with MeOH-H2O (3:2, v/v) to give D7A (26.1 378 
mg) and further separation on a silica gel CC eluting with CH2Cl2-MeOH (97:3, v/v) 379 
to yield compound 5 (0.8 mg). Fraction E (14.9 mg) was subjected to RP C8 HPLC 380 
(eluted with CH3CN/H2O with 0.05% TFA, 3:2, 2 mL/min) to give compound 2 (1.0 381 
mg, tR = 12.8 min) and compound 1 (2.1 mg, tR = 13.6 min). Fraction F (8.9 g) was 382 
partition with CH2Cl2 and water, the CH2Cl2 soluble fraction (7.9 g) was subjected to 383 
silica gel CC, eluting with a gradient of CH2Cl2-MeOH (99:1 to 19:1, v/v) to afford 7 384 
subfractions (F1−F7). Fraction F2 (912.8 mg) was chromatographed on a silica gel 385 
CC eluting with CH2Cl2-MeOH (99:1, v/v) to afford compound 4 (1.1 mg) and 4 386 
subfractions (F2-1−F2-4). Fraction F2-2 (588.0 mg) was subjected to Sephadex LH-387 
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20 CC (100% MeOH) to afford 5 subfractions (F2-2-1−F2-2-5). Fraction F2-2-1 388 
(114.5 mg) was purified using RP C8 HPLC (eluted with CH3CN/H2O with 0.05% 389 
TFA, 3:7, 2 mL/min) to afford compounds 8 (1.1 mg, tR = 34.9 min), 9 (0.3 mg, tR = 390 
48.7 min), and seven subfractions (F2-2-1-1−F2-2-1-7). Fraction F2-2-1-3 and F2-2-391 
1-6 were subjected to RP C8 HPLC (eluted with CH3CN/H2O with 0.05% TFA, 3:7, 2 392 
mL/min) to yield compounds 16 (7.7 mg, tR = 40.5 min), 13 (1.3 mg, tR = 62.9 min), 7 393 
(0.9 mg, tR = 70.0 min), 14 (1.7 mg, tR = 81.9 min), and 15 (1.1 mg, tR = 91.4 min). 394 
Fraction F2-2-2 (257.7 mg) was chromatographed on silica CC eluting with n-395 
hexanes-acetone (7:3, v/v) to give 5 subfractions (F2-2-2-1−F2-2-2-5). Fraction F2-2-396 
2-2 (11.8 mg) was subjected to RP C8 HPLC (eluted with CH3CN/H2O with 0.05% 397 
TFA, 3:7, 2 mL/min) to yield compound 26 (0.7 mg, tR = 20.6 min). Compound 20 398 
(3.9 mg, tR = 29.1 min), enantiomeric mixtures of 17 and 18 (1.9 mg, tR = 15.2 min), 399 
23 and 21 (0.7 mg, tR = 29.1 min) and 19 and 22 (15.7 mg) were obtained from 400 
fraction F2-2-2-4 (28.5 mg). The chiral column OD-H (eluted with n-hexanes/MeOH, 401 
3:2, 2 mL/min) was used to yield compounds 17 (0.2 mg, tR = 10.9 min) and 18 (0.4 402 
mg, tR = 11.4 min), 23 (0.3 mg, tR = 9.2 min) and 21 (0.2 mg, tR = 10.9 min), and 19 403 
(5.2 mg, tR = 6.3 min) and 22 (6.9 mg, tR = 7.4 min). Fraction F2-2-4 (13.7 mg) was 404 
subjected to RP C18 HPLC (eluted with CH3CN/H2O with 0.05% TFA, 2:3, 2 405 
mL/min) to give compounds 24 (0.5 mg, tR = 14.1 min) and 25 (1.9 mg, tR = 11.8 406 
min). Compound 3 (1.8 mg, tR = 15.9 min) was purified by RP C8 HPLC (eluted with 407 
CH3CN/H2O with 0.05% TFA, 3:7, 2 mL/min) from fraction F2-2-5 (8.4 mg). 408 
Compound 34 (1.0 mg, tR = 9.9 min) was purified from fraction F3 (435.7 mg) by 409 
QCC over silica gel, eluting with a gradient of CH2Cl2-MeOH gradient (99:1 to 97:3, 410 
v/v) to give 4 subfractions (F3-1−F3-4), with each of these purified with RP C18 411 
HPLC (eluted with CH3CN/H2O with 0.05% TFA, 2:3, 2 mL/min) and Sephadex LH-412 
20 (100% MeOH). Fraction G (10.8 g) was chromatographed on a silica gel CC 413 
eluting with CH2Cl2-MeOH (95:5, v/v) to give 10 subfractions (G1‒G10). Fraction 414 
G3 (15.7 mg) was purify using RP C8 HPLC (eluted with CH3CN/H2O with 0.05% 415 
TFA, 3:7, 2 mL/min) to give compound 12 (1.7 mg, tR = 7.4 min). Fraction G4 (142.3 416 
mg) was subjected to silica gel CC, eluted with CH2Cl2-MeOH (97:3, v/v) following 417 
RP C8 HPLC (eluted with CH3CN/H2O with 0.05% TFA, 1:3, 2 mL/min) to give 418 
compounds 27 (5.2 mg, tR = 14.2 min), 10 (0.4 mg, tR = 23.3 min), and 11 (0.3 mg, tR 419 
= 24.6 min). Compound 6 (36.9 mg) was recrystallized from n-hexanes-acetone (1:1, 420 
v/v) from subfraction G6 (234.7 mg).  421 
 The dried leaves of G. cheliensis (412.1 g) were extracted with acetone (3 × 3 422 
L) at room temperature. The acetone extract (33.8 g) was subjected to QCC over silica 423 
gel, eluting with a gradient of n-hexanes-acetone gradient (1:0 to 0:1, v/v) to afford 424 
fourteen fractions (A‒N). The combined of fraction E‒H were further separated on a 425 
Sep-Pak C18 CC eluting with MeOH-H2O (1:1, v/v) to give fraction B1 (819.4 mg) 426 
and further separation by silica gel CC, eluting with n-hexanes-acetone (9:1, v/v) gave 427 
5 subfractions (B1-1‒B1-5). Fraction B1-3 (73.2 mg) was purified by RP C8 HPLC 428 
(eluted with CH3CN/H2O with 0.05% TFA, 3:2, 2 mL/min) to yield compounds 37 429 
(2.0 mg, tR = 24.7 min) and 42 (1.3 mg, tR = 37.3 min). The combination of fraction 430 
I‒K was subjected to Sep-Pak C18 CC eluting with MeOH-H2O (1:1, v/v) to give 431 
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fraction C1 (806.4 mg) and further separation by Sephadex LH-20 CC (100% MeOH) 432 
to yield six subfractions (C1-1‒C1-6). Fraction C1-3 (8.7 mg) was purified by silica 433 
gel CC, eluting with n-hexanes-acetone (7:3, v/v) to give compound 39 (1.7 mg) and 434 
5 subfractions (C1-3-1‒C1-3-5). Compounds 36 (1.4 mg, tR = 32.8 min) and 41 (0.9 435 
mg, tR = 34.0 min) were obtained from subfraction C1-3-5 (4.5 mg), by a RP C8 436 
HPLC (eluted with CH3CN/H2O with 0.05% TFA, 1:1, 2 mL/min). After further 437 
purification by RP C8 HPLC (eluted with CH3CN/H2O with 0.05% TFA, 1:1, 2 438 
mL/min), compounds 38 (2.1 mg, tR = 20.7 min) and 40 (0.4 mg, tR = 23.5 min) were 439 
obtained from subfraction C1-4 (6.1 mg). The combined of fractions L‒N were 440 
further separated by Sephadex LH-20 CC (100% MeOH) to give nine subfractions 441 
(D1‒D9). Fraction D6 (18.2 mg) was isolated by RP C18 HPLC (eluted with 442 
CH3CN/H2O with 0.05% TFA, 3:7, 2 mL/min) to afford compounds 43 (0.3 mg, tR = 443 
28.9 min) and 44 (0.8 mg, tR = 30.5 min).  444 
 445 
4.3.1 Goniochelienic acid A (1) 446 
  Yellow needle; mp 215−217 oC; UV (MeOH) λmax (log ε) 253 (3.47), 287 447 
(3.08), 328 (2.51) nm; IR (neat) υmax 2920, 2850, 1721, 1451, 1236, 747 cm
-1; For 1H-448 
NMR (600 MHz, CDCl3) and 
13C-NMR (125 MHz, CDCl3), see Table 1; HRESIMS 449 
(positive-ion mode) m/z 294.0379 [M + Na]+ (calcd for C14H9NO5Na, 294.0378).    450 
 451 
4.3.2 Goniochelienic acid B (2) 452 
  Yellow amorphous solid; mp 220−222 oC; UV (MeOH) λmax (log ε) 253 453 
(3.74), 278 (3.33), 331 (2.95) nm; IR (neat) υmax 2918, 2850, 1727, 1459, 1228, 717 454 
cm-1; For 1H-NMR (600 MHz, CDCl3) and 
13C-NMR (125 MHz, CDCl3), see Table 1; 455 
HRESIMS (positive-ion mode) m/z 278.0436 [M + Na]+ (calcd for C14H9NO4Na, 456 
278.0429).    457 
 458 
4.3.3 Methyl goniochelienate (3) 459 
 Yellow solid; mp 214−216 oC; UV (MeOH) λmax (log ε) 251 (4.37), 276 460 
(3.95), 309 (3.53), 3.74 (3.13) nm; IR (neat) υmax 2924, 2853, 1678, 1208, 1135 cm
-1; 461 
For 1H-NMR (600 MHz, MeOH-d4) and 
13C-NMR (125 MHz, MeOH-d4), see Table 462 
1; HRESIMS (positive-ion mode) m/z 278.0435 [M + Na]+ (cald for C14H9NO4Na, 463 
278.0429).   464 
 465 
4.3.4 Goniochelieninone (5) 466 
 Yellow solid; mp 162−165 oC; UV (MeOH) λmax (log ε) 215 (3.53), 282 467 
(3.20), 417 (2.59) nm; IR (neat) υmax 3335, 3215, 2920, 2851, 1615, 1452, 1371, 1260 468 
cm-1; For 1H-NMR (600 MHz, CDCl3) and 
13C-NMR (125 MHz, CDCl3), see Table 2; 469 
HRESIMS (positive-ion mode) m/z 284.0530 [M + Na]+ (calcd for C13H11NO5Na, 470 
284.0535).   471 
  472 
4.3.5 (−)-(4S,5S,6R,7S,8S)-Goniochelienlactone (6) 473 
 Colorless solid; mp 215−217 oC; [α]25D
 −47.0 (c 0.1, EtOH); UV (EtOH) λmax 474 
(log ε) 215 (2.76), 255 (1.51) nm; CD (EtOH) λmax (∆ε) 227 (−0.89) nm; IR (neat) 475 
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υmax 3395, 2925, 2873, 2853, 1713, 1177, 1081 cm
-1; 1H NMR (600 MHz, DMSO-d6) 476 
and 13C NMR (125 MHz, DMSO-d6) data, see Table 3; HRESIMS (positive-ion 477 
mode) m/z 273.0749 [M + Na]+ (calcd for C13H14O5Na, 273.0739).   478 
 479 
4.3.6 (−)-(4S,5S,6R,7S,8S)-7-acetylgoniochelienlactone (7) 480 
 Colorless solid; mp 152−155 oC; [α]25D −58.0 (c 0.1, EtOH); UV (EtOH) λmax 481 
(log ε) 212 (2.69), 249 (0.97) nm; CD (EtOH) λmax (∆ε) 232 (−0.26) nm; IR (neat) 482 
υmax 3422, 2924, 1731, 1220, 1054 cm
-1; 1H NMR (600 MHz, CDCl3) and 
13C NMR 483 
(125 MHz, CDCl3) data, see Table 3; HRESIMS (positive-ion mode) m/z 315.0854 484 
[M + Na]+ (calcd for C15H16O6Na, 315.0845).   485 
 486 
4.3.7 (+)-(7S,8S)-Goniochelienbutenolide A (8) 487 
 Colorless viscous; [α]25D +55.0 (c 0.1 EtOH); UV (EtOH) λmax (log ε) 206 488 
(2.9), 273 (2.8) nm; CD (EtOH) λmax (∆ε) 227 (−0.30), 274 (−0.59) nm; IR (neat) υmax 489 
3419, 2926, 1682, 1750, 1208, 1135 cm-1; 1H NMR (600 MHz, acetone-d6) and 
13C 490 
NMR (125 MHz, acetone-d6) data, see Table 4; HRESIMS (positive-ion mode) m/z 491 
297.0730 [M + Na]+ (calcd for C15H14O5Na, 297.0739).   492 
 493 
4.3.8 (−)-(7S,8R)-Goniochelienbutenolide B (9) 494 
 Colorless viscous; [α]25D −34.0 (c 0.1 CHCl3); UV (CHCl3) λmax (log ε) 225 495 
(2.9), 274 (2.8) nm; CD (CHCl3) λmax (∆ε) 228 (+0.04), 281 (+0.76) nm; IR (neat) 496 
υmax 3472, 2922, 2852, 1743, 1236 cm
-1; 1H NMR (600 MHz, CDCl3) and 
13C NMR 497 
(125 MHz, CDCl3) data, see Table 4; HRESIMS (positive-ion mode) m/z 297.0746 498 
[M + Na]+ (calcd for C15H14O5Na, 297.0739).   499 
 500 
4.4 X-ray crystal analysis of compounds 1, 4, 6, and 7 501 
 X-ray diffraction data were collected using Mo Kα radiation (λ = 0.71073 Å) 502 
and Cu Kα radiation (λ = 1.54178 Å) on a Bruker APEX-II CCD diffractometer. 503 
Using Olex2 (Dolomanov et al., 2009), the structure was solved with the XT 504 
(Sheldrick, 2015) structure solution program, using the Intrinsic Phasing solution 505 
method. The model was refined with version 2018/1 of XL (Sheldrick, 2015) using 506 
Least Squares minimisation. Crystallographic data of compounds 1, 4, 6, and 7 have 507 
been deposited at the Cambridge Crystallographic Data Center under the reference 508 
number CCDC 1846457 (1), 1846454 (4), 1846455 (6), and 1846456 (7). These data 509 
can be obtained, free of charge, from the Cambridge Crystallographic Data Centre via 510 
http://www.ccdc.cam.ac.uk/data_request/cif.  511 
 512 
4.4.1 Crystal data of 1 513 
 Crystals of 1 were obtained as orange irregular-shaped crystals from Me2CO-514 
hexanes. C31H24N2O11, Mr = 600.52, monoclinic, space group C2/c (No. 15), a = 515 
13.549(6) Å, b = 26.964(12) Å, c = 8.522(4) Å, β = 122.191(10)°, α = γ = 90°, V = 516 
2635(2) Å3, T = 90(2) K, Z = 4, Z' = 0.5, µ(Mo Kα) = 0.117, 9693 reflections 517 
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measured, 1731 unique (Rint = 0.0813) which were used in all calculations. The final 518 
wR2 was 0.1937 (all data) and R1 was 0.0692 (I > 2(I)). 519 
4.4.2 Crystal data of 4 520 
 Crystals of 4 were obtained as orange needle-shaped crystals from Me2CO-521 
hexanes. C13H9NO2, Mr = 211.21, monoclinic, space group P21/c (No. 14), a = 522 
15.1793(14) Å, b = 3.8477(5) Å, c = 17.6197(18) Å, β = 109.578(5)°, α = γ = 90°, V = 523 
969.59(19) Å3, T = 100(2) K, Z = 4, Z' = 1, µ(Mo Kα) = 0.099, 9656 reflections 524 
measured, 2298 unique (Rint = 0.0343) which were used in all calculations. The final 525 
wR2 was 0.1790 (all data) and R1 was 0.0602 (I > 2(I)). 526 
 527 
4.4.3 Crystal data of 6 528 
 Crystals of 6 were obtained as colourless irregular-shaped crystals from 529 
Me2CO-hexanes. C13H14O5, Mr = 250.24, orthorhombic, space group P212121 (No. 530 
19), a = 9.4413(5) Å, b = 10.3844(6) Å, c = 11.6131(6) Å, α = β = γ = 90°, V = 531 
1138.57(11) Å3, T = 90(2) K, Z = 4, Z' = 1, µ(Cu Kα) = 0.948, 9069 reflections 532 
measured, 2012 unique (Rint = 0.0325) which were used in all calculations. The final 533 
wR2 was 0.0615 (all data) and R1 was 0.0241 (I > 2(I)). Flack parameter = -0.04(7).   534 
 535 
4.4.4 Crystal data of 7 536 
 Crystals of 7 were obtained as colourless irregular-shaped crystals from 537 
Me2CO-hexanes. C15H16O6, Mr = 292.28, monoclinic, P21 (No. 4), a = 10.9487(4) Å, 538 
b = 6.8358(3) Å, c = 18.6909(7) Å, β = 90.243(2)°, α = γ = 90°, V = 1398.87(10) Å3, T 539 
= 90(2) K, Z = 4, Z' = 2, µ(Cu Kα) = 0.910, 20213 reflections measured, 4945 unique 540 
(Rint = 0.0351) which were used in all calculations. The final wR2 was 0.0900 (all 541 
data) and R1 was 0.0336 (I > 2(I)). Flack parameter = 0.00(11). 542 
 543 
4.5 Biological assay 544 
4.5.1 Bioassay for Cytotoxicity 545 
 The cytotoxicities of compounds on colon cancer cell were performed 546 
following by the previous method (Sriyatep et al., 2017). Doxorubicin used as a 547 
positive control (IC50 = 9.74 µM).  548 
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Eight previously undescribed compounds were isolated and characterized from Goniothalamus 
cheliensis. Griffithazanone A showed potent cytotoxicities against human colorectal cancer cells 
(HCT-116). 
 
Figure legends 
Fig. 1. The structures of compounds from G. cheliensis twigs. 
Fig. 2. The structures of compounds from G. cheliensis leaves. 
Fig. 3. The key COSY and HMBC correlations of 1−3 and 5−9. 
Fig.4. The key NOESY correlations of 6 and 7 (molecular structures generated using 3D 
structure ChemBioDraw Ultra 11.0). 
Fig. 5. Single crystal X-ray structure of 1. 
Fig. 6. Single crystal X-ray structure of 4. 
Fig. 7. Single crystal X-ray structure of 6. 
Fig. 8. Single crystal X-ray structure of 7. 
Fig. 9. ECD spectra of 6 and 7. 
Fig. 10. ECD spectra of 8−11. 
Fig. 11. Plausible biosynthetic pathway of 1−4 (a) and 5 (b). 
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Table 1  
1H (600 MHz) and 13C (150 MHz) NMR Spectroscopic data of 1−3. 
 1 (CDCl3)  2 (CDCl3)  3 (methanol-d4) 
position δC, type δH (J in Hz)  δC, type δH (J in Hz)  δC, type δH (J in Hz) 
2 138.0, CH 7.74, s  137.5, CH  7.73, s  130.2, CH 7.81, s 
3 114.5, C   116.4, C   115.2, C  
3a 123.5, C   123.1, C   124.0, C  
4 183.1, C   184.0, C   179.1, C  
4a 132.0, C   132.6, C   133.7, C  
5 120.7, CH 7.82, d (7.4)  127.4, CH 8.26, dd (7.4, 1.3)  124.0, CH 8.14, dd (7.8, 1.2) 
6 136.0, CH 7.64, dd (7.8, 7.4)  134.5, CH 7.79, td (7.5, 1.5)  132.1, CH 7.78, dd (7.2, 1.2) 
7 126.1, CH 7.32, d (7.8)  133.6, CH 7.81, td (7.5, 1.5)  131.4, CH 7.77, ddd (7.8, 7.2, 1.2) 
8 162.5, C   126.6, CH 8.21, dd (7.4, 1.3)  125.2, CH 8.19, dd (7.8, 1.2) 
8a 114.5, C   132.6, C   133.0, C  
9 180.9, C   175.5, C   175.3, C  
9a 130.9, C   131.8, C   134.4, C  
10 161.5, C   162.1, C   163.2, C  
N-Me 37.5, CH3 4.15, s  37.3, CH3 4.16, s    
8-OH  12.20, s       
3-CO2Me        49.3, CH3 3.89, s 
3-COOH  13.68, s   13.70, s    
 
 
 
 
 
 
 
 
Table 2 
 
1H (600 MHz) and 13C (150 MHz) NMR Spectroscopic data of 5 and goniothalaminone B.  
 5 (DMSO-d6)  5 (CDCl3)  goniothalaminone B (CDCl3) 
position δC, type δH (J in Hz)  δC, type δH (J in Hz)  δC, type δH (J in Hz) 
1 178.1, C   178.0, C   180.2, C  
2 107.5, C   106.9, C   109.4, C  
3 155.0, C   158.4, C   152.5, C  
4 187.7, C   186.3, C   185.5, C  
4a 114.3, C   113.4, C   114.0, C  
5 151.6, C   151.8, C   152.0, C  
6 155.8, C   155.8, C   152.1, C  
7 114.7, CH 7.29, d (8.4)  113.2, CH 7.05, d (8.4)  117.8, C 7.22, d (8.4) 
8 120.7, CH 7.62, d (8.4)  121.0, CH 7.75, d (8.4)  120.7, C 7.76, d (8.4) 
8a 121.8, C   126.7, CH   125.0, C  
5-OH  13.94, s   13.97, s   11.71, s 
6-OMe 56.2, CH3 3.91, s  56.0, CH3 4.02, s  56.4, CH3 3.99, s 
NH2  9.12, br s      7.07, br s 
  10.68, br s      10.66, br s 
COMe 199.9, C   200.7, C   202.4, C  
COMe 33.2, CH3 2.56, s  33.0, CH3 2.73, s  33.2, CH3 2.73, s 
 
 
Table 3 
1H (600 MHz) and 13C (150 MHz) NMR Spectroscopic data of 6 and 7.  
 6 (DMSO-d6)  7 (CDCl3) 
position δC, type δH (J in Hz)  δC, type δH (J in Hz) 
2 168.7, C   167.0, C  
3ax 35.2, CH2 
2.78, d (19.3)  
34.6, CH2 
3.15, dd (19.6, 1.2) 
3eq 3.07, d (19.3, 5.2)  3.02, dd (19.6, 5.2) 
4 69.3, CH 4.07, d (4.6)  69.7, CH 4.38, m 
5 64.7, CH 4.15, td (4.3, 1.6)  65.3, CH 4.33, dd (4.6, 1.6) 
6 78.4, CH 4.45, m  74.5, CH 4.91, dt (4.6, 2.6) 
7 67.2, CH 3.87, ddd (9.8, 7.2, 2.3)  69.1, CH 5.37, dd (10.3, 2.6) 
8 72.9, CH 4.24, d (9.8)  70.6, CH 4.67, d (10.3) 
1ʹ 139.7, C   136.0, C  
2ʹ 128.7, CH 7.38, d (7.9)  126.7, CH 7.41, m 
3ʹ 127.7, CH 7.30, t (7.6)  128.1, CH 7.37, m 
4ʹ 127.6, CH 7.26, t (7.2)  128.6, CH 7.34, m 
5ʹ 127.7, CH 7.30, t (7.6)   7.37, m 
6ʹ 128.7, CH 7.38, d (7.9)   7.41, m 
5-OH  5.70, d (4.0)    
7-OH  5.16, d (6.9)    
7-OCOMe    169.1, C  
7-OCOMe    20.2, CH3 1.94, s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 
1H (600 MHz) and 13C (150 MHz) NMR Spectroscopic data of 8 and 9.  
 8 (acetone-d6)  9 (CDCl3) 
position δC, type δH (J in Hz)  δC, type δH (J in Hz) 
2 168.2, C   169.6, C  
3 119.6, CH 6.31, d (5.5)  121.2, CH 6.19, dd (5.6, 1.5) 
4 114.0, CH 7.74, d (5.5)  139.6, CH 7.50, d, (5.6) 
5 149.8, C   152.4, C  
6 112.9, CH 5.46, d (9.2)  107.0, CH 5.82, dd (10.0, 1.5) 
7 67.8, CH 4.98, dd (9.2, 5.3)  72.3, CH 5.69, dd (10.0, 4.2) 
8 76.5, CH 5.85, d (5.3)  74.8, CH 5.06, d (4.2) 
1ʹ 135.8, C   137.4, C 
7.34-7.38, m 
2ʹ 126.7, CH 7.40, d (7.4)  125.9, CH 
3ʹ 127.5, CH 7.33, t (7.4)  128.1, CH 
4ʹ 127.3, CH 7.27, t (7.3)  128.8, CH 
5ʹ 127.5, CH 7.33, t (7.4)  128.1, CH 
6ʹ 126.7, CH 7.40, d (7.4)  125.9, CH 
8-OCOMe 168.0, C   168.2, C  
8-OCOMe 19.5, CH3 2.00, overlapped  21.0, CH3 2.07, s 
 
 
 
 
  
